The women's health therapeutics market share is expected to increase by USD 30.35 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.74%.

This women's health therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers women's health therapeutics market segmentation by type (fertility, oncology, menopause, infection, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The women's health therapeutics market report also offers information on several market vendors, including Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA among others.

What will the Women's Health Therapeutics Market Size be During the Forecast Period?

Download Report Sample to Unlock the Women's Health Therapeutics Market Size for the Forecast Period and Other Important Statistics

Women's Health Therapeutics Market: Key Drivers, Trends, and Challenges

The strategic alliances are notably driving the women's health therapeutics market growth, although factors such as side effects of approved drugs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the women's health therapeutics industry. The holistic analysis of the drivers will help deduce end goals and refine marketing strategies to gain a competitive edge.

Key Women's Health Therapeutics Market Driver

Strategic alliances is one of the major driver impacting the women's health therapeutics market growth. The global women's health therapeutics market has witnessed multiple strategic alliances between vendors in recent years. The drug development process requires a highly advanced R&D team, which most mid-sized and small pharmaceutical vendors lack. Similarly, these small- and mid-sized pharmaceutical vendors have low profitability, as they do not often achieve economies of scale. Similarly, the lack of an established distribution network globally poses a threat to some vendors, which is limiting their geographical presence in the market. As a result, multiple vendors in the market are entering into collaborative agreements to overcome the challenges associated with the research, manufacturing, and commercialization of drugs in new regions. Hence, increasing alliances are expected to help in overcoming the research and commercialization challenges that currently exist, thereby making the treatment reach a large patient population. Hence, the increasing number of strategic alliances is expected to contribute significantly to the growth of the global women's health therapeutics market during the forecast period.

Key Women's Health Therapeutics Market Trend

Rising awareness of gynecological diseases is one of the major trends influencing the women's health therapeutics market growth. Multiple organizations are striving to increase awareness among people about gynecological diseases such as cancer, maternity disorders, and infectious diseases. For instance, the Centers for Disease Control and Prevention (CDC) conducts a campaign called Inside Knowledge: Get the Facts About Gynecologic Cancer, which provides the public with access to information about gynecological cancers. Worldwide events such as Ovarian Cancer Awareness Month and Uterine Cancer Awareness Month conducted in September also aim to raise awareness about these diseases. Likewise, the Foundation for Women Cancer in the US observes September as Gynecologic Cancer Awareness Month every year. Moreover, some organizations work toward increasing patient awareness regarding all the major sub-types of gynecological disorders. The American Cancer Society also works to promote awareness of cancers such as cervical cancer and encourages women to get tested for cervical cancer. Such rising awareness of gynecological diseases is anticipated to drive the growth of the global women's therapeutics market during the forecast period.

Key Women's Health Therapeutics Market Challenge

Side effects of approved drugs are one of the major challenges impeding the women's health therapeutics market growth. Chemotherapy has harmful side effects as it involves the use of cytotoxic drugs to destroy cancer cells. Cytotoxic drugs cannot distinguish between healthy and cancerous cells, because of which they also destroy the healthy peripheral cells that surround the cancer cells. The destruction of normal healthy cells leads to cytotoxic side effects. Some most common side effects encountered with chemotherapy are alopecia, fatigue, myelosuppression, neurotoxicity, gastrointestinal toxicity, cutaneous reactions, reduced libido, and fertility problems. Side effects such as myelosuppression result in anemia, thrombocytopenia, neutropenia, and arthralgia, which, in turn, require additional therapies. For instance, neutropenia is known to occur in patients treated with certain cytotoxic drug regimens. These patients require infusions of granulocyte colony-stimulating factors until the white blood cells have fully recovered. Hence, to avoid such harmful side effects, patients are opting for substitutes such as debulking surgery, thereby restricting the growth of the market. Hence, the serious side effects caused by the approved drugs are expected to limit the growth of the women's health therapeutics market during the forecast period.

This women's health therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global women's health therapeutics market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the women's health therapeutics market during the forecast period.

Who are the Major Women's Health Therapeutics Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

• Abbott Laboratories
• AbbVie Inc.
• Amgen Inc.
• Bayer AG
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GLS Pharma Pvt. Ltd.
• ICON plc
• Merck KGaA
• Novartis AG
• Novo Nordisk AS
• ObsEva SA
• Pfizer Inc.
• Radius Health Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• TSUMURA and Co.
• Vivesto AB
• Mithra Pharmaceuticals SA

This statistical study of the women's health therapeutics market encompasses successful business strategies deployed by the key vendors. The women's health therapeutics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The women's health therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Women's Health Therapeutics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the women's health therapeutics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for the Women's Health Therapeutics Market?

For more insights on the market share of various regions Request PDF Sample now!

37% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for women's health therapeutics market in North America. Market growth in this region will be faster than the growth of the market in other regions.

Increasing the adoption of novel therapeutics for the treatment of diseases such as anticancer drugs will facilitate the women's health therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 hurt the market in focus in this region in 2020. Owing to the harmful effects of COVID-19, a considerable number of treatment facilities laid off their employees in 2020. As a result, treatment facilities for the gynecological disorder had to face personnel and stockpile shortages, which, in turn, led to disruptions in the supply chain and production of therapeutics such as anticancer drugs. 

What are the Revenue-generating Type Segments in the Women's Health Therapeutics Market?

To gain further insights on the market contribution of various segments Request a PDF Sample

The women's health therapeutics market share growth in the fertility segment will be significant during the forecast period. The rise in the incidence of gynecological cancers in countries such as the US and Canada is driving the women's health therapeutics market. For instance, it is estimated that around 14,100 women living in the US will be diagnosed with cervical cancer, and more than 4,280 women may die from cervical cancer in 2022 despite undergoing screening and treatment.

This report provides an accurate prediction of the contribution of all the segments to the growth of the women's health therapeutics market size and actionable market insights on post COVID-19 impact on each segment.

Request PDF sample

What are the Key Data Covered in this Women's Health Therapeutics Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive women's health therapeutics market growth during the next five years
• Precise estimation of the women's health therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the women's health therapeutics industry across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of women's health therapeutics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch